Inspiring BOLD Ideas in Pharma
BOLDpharma is an initiative launched earlier this year by digital agency Anthill, together with key industry figures, to address the lack of confidence the industry has sometimes shown, and which makes it hard to launch "big ideas that create real change". The initiative is designed "to be the thought provocation that our industry needs, and to inspire and build a community of like-minded individuals to encourage innovation in pharma – confident, challenging, bold-thinking people who will drive the industry’s development in the years to come", says the agency.
One of the initial calls to action is the BOLD Survey, which has just been launched to uncover precisely what is holding people back. Initial results highlight the great potential for the industry to work in new ways – but there needs to be action. 89% of respondents believed that their organization is not fully-utilizing the technology at their disposal and less than 20% believed that an innovative initiative would be supported within their organization.
"This movement has the potential to drastically improve the state of healthcare. There’s strength in numbers and the BOLD movement has already begun highlighting that the numbers are on the side of pro-active change," says Anthill.
To be part of the BOLDpharma initiative, follow this link to take part in the survey and receive a personal profile in relation to some key BOLD metrics. Further information can be found on Twitter, @BOLDpharma and the BOLDPharma website.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
